# A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

> clinical trial · VERIFIED · 2026-07-06

Status: ACTIVE_NOT_RECRUITING · Sponsor: Regeneron Pharmaceuticals · Condition: Melanoma

- Company: Regeneron Pharmaceuticals
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05608291

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.